Nivestym (filgrastim-aafi) Injection, 480 mcg/1.6 mL Single-Dose Vial, 10/Package
Nivestym (filgrastim-aafi) is a leukocyte growth factor indicated to decrease the incidence of infection in patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs. This formulation is supplied as a 480 mcg/1.6 mL solution in single-dose vials, packaged 10 vials per package. It is a biosimilar to Neupogen and is administered by subcutaneous or intravenous injection.
Vendor Pricing Comparison
Sorted by lowest price · Add now, sign in at checkout
Vendor Pricing Comparison
Sorted by lowest price · Add now, sign in at checkout
Nivestym (filgrastim-aafi) is a leukocyte growth factor indicated to decrease the incidence of infection in patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs. This formulation is supplied as a 480 mcg/1.6 mL solution in single-dose vials, packaged 10 vials per package. It is a biosimilar to Neupogen and is administered by subcutaneous or intravenous injection.
1 vendor
